Current COVID-19 vaccine studies
The UK is a leading force in the development of vaccines for COVID-19. Search our database of studies and trials currently under way.
This study aims to understand, at a qualitative and quantitative level, immune response durability in 'real-life settings' of different vaccination regimens for individuals who are over 80 years of age living in the community in the UK. To achieve this, we will track longitudinal immunity, analysing serum antibody titre and live virus neutralisation, both to wild-type and variant targets. In terms of T cell immunity, we will track durability of response and frequency to wild-type and variant epitopes using a range of approaches.
The National Core Studies Programme (NCS) immunity